Artha Sootra - Company Dashboard

Governance Classic Home

Venus Remedies LtdPharmaceuticalsINE411B01019Consolidated₹1380.90+65.70 (+5.00%)

Valuation

Market Cap₹1.85K Cr

TTM PE15.17x

Forward PE14.40x

PEG3.19

Book Value₹527.05

P/B2.62x

TTM EPS₹91.04

Fwd EPS₹95.87

TTM Revenue₹837.28 Cr

TTM PAT₹121.69 Cr

TTM EBITDA₹177.63 Cr

TTM EBIT₹148.00 Cr

Last Qtr PAT₹25.65 Cr

Last Qtr EBITDA₹42.50 Cr

Last Qtr EBIT₹32.96 Cr

Profitability

ROE17.27%

ROCE22.47%

TTM NPM14.53%

TTM EBITDA %21.22%

Curr OPM11.70%

Last OPM12.66%

Curr NPM—

Last NPM—

Curr EPS₹19.19

Last EPS₹17.18

Balance sheet

Equity₹13.37 Cr

Reserve₹691.14 Cr

Total Debt₹1.42 Cr

D/E0.00x

Interest %0.00%

Curr Interest₹0.00 Cr

Price / range

Close₹1380.90

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+5.00%

1W+3.81%

1M-23.14%

3M-11.08%

6M+40.34%

1Y+211.50%

2Y+344.38%

3Y+424.56%

5Y+160.69%

Diwali+82.59%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1773.40	₹4.25L Cr	38.81	12.31%
DIVISLAB	10037.50	₹2.66L Cr	91.08	17.45%
TORNTPHARM	4738.50	₹1.60L Cr	77.77	11.42%
LAURUSLABS	2323.80	₹1.25L Cr	93.63	21.98%
ZYDUSLIFE	1188.10	₹1.20L Cr	28.53	15.79%
DRREDDY	1374.00	₹1.15L Cr	40.89	7.11%
CIPLA	1402.00	₹1.13L Cr	39.09	8.06%
MANKIND	2537.90	₹1.05L Cr	46.71	12.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	218.76+13.6%	178.80	259.01	179.95	192.65	768.73
Other Income	0.40	2.55	4.64	2.41	1.68	11.45
Total Income	219.16+12.8%	181.35	263.65	182.36	194.33	780.18
Interest	0	0	0	0	0	0
Expenditure	-182.39-8.1%	-148.75	-206.07	-149.55	-168.73	-649.50
PBDT	0	0	0	0	0	0
EBITDA	45.64+52.9%	36.56	59.44	36.72	29.84	143.92
Depreciation	-9.27	-6.51	-6.50	-6.32	-5.92	-24.69
EBIT	36.37+52.0%	30.05	52.94	30.40	23.92	119.23
PBT	36.77+43.6%	32.60	57.58	32.81	25.60	130.68
Tax	-7.81	-7.07	-14.11	-7.89	-6.36	-31.37
Equity	13.37	13.37	13.37	0	0	13.37
OPM	16.78	17.98	21.84	18.23	13.29	16.75
Net Profit	28.96+50.5%	25.53	43.47	24.92	19.24	99.31
NPM	13.21	14.08	16.49	13.85	9.99	12.73
EPS	21.66+50.4%	19.10	32.51	18.64	14.40	74.29

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 18-19	FY 17-18	FY 16-17
Revenue	768.73+20.2%	639.46+11.2%	575.21	301.84-15.0%	355.07-5.4%	375.45
Other Income	11.45	20.78	11.32	4.51	0.72	0.79
Total Income	780.18+18.2%	660.24+12.6%	586.53	306.35-13.9%	355.79-5.4%	376.24
Expenditure	-649.50-9.9%	-591.09-9.5%	-539.88	-325.65+6.0%	-346.49-3.7%	-333.97
Interest	0	0	0	-25.15	-34.98	0
PBDT	0	0	0	0	9.30	1.04
EBITDA	143.92+105.6%	69.99+15.0%	60.88	34.29-55.1%	76.29+83.9%	41.48
Depreciation	-24.69	-21.62	-25.55	-32.95	-32.73	0
EBIT	119.23+146.5%	48.37+36.9%	35.33	1.34-96.9%	43.56+5.0%	41.48
PBT	130.68+65.3%	79.06+69.5%	46.65	-28.26-20.7%	-23.42-2351.9%	1.04
Tax	-31.37	-23.58	-16.15	1.15	-3.16	3.70
Equity	13.37	13.37	0	0	12.34	12.34
OPM (%)	16.75	11.97	8.00	-9.00	2.62	0.28
Net Profit	99.31+89.0%	52.55+72.3%	30.50	-27.11-2.0%	-26.58-659.6%	4.75
NPM (%)	12.73	7.96	5.00	-9.00	-7.49	1.26
EPS (Rs)	74.29+88.9%	39.32+72.3%	22.82	-21.97-2.0%	-21.54	0
CEPS	74.29	39.32	22.82	-21.97	4.98	3.85

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	218.76+13.5%	178.86	259.40	180.26	192.75	769.60
Other Income	0.51	2.62	4.95	2.52	1.71	12.58
Total Income	219.27+12.8%	181.48	264.35	182.78	194.46	782.18
Interest	0	0	0.01	0.01	0.01	0.04
Expenditure	-185.80-10.6%	-151.44	-202.75	-149.31	-167.97	-648.03
PBDT	0	0	0	0	0	0
EBITDA	42.50+37.3%	34.19	63.42	37.52	30.96	147.28
Depreciation	-9.54	-6.77	-6.76	-6.56	-6.17	-25.67
EBIT	32.96+33.0%	27.42	56.66	30.96	24.79	121.61
PBT	33.47+26.3%	30.04	61.60	33.47	26.49	134.15
Tax	-7.82	-7.07	-14.11	-7.89	-6.36	-31.37
Equity	13.37	13.37	13.37	0	0	13.37
OPM	15.26	16.55	23.30	18.31	13.62	17.15
Net Profit	25.65+27.4%	22.97	47.49	25.58	20.13	102.78
NPM	11.70	12.66	17.96	13.99	10.35	13.14
EPS	19.19+27.4%	17.18	35.53	19.14	15.06	76.89

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 18-19
Revenue	769.60+18.8%	647.89+7.7%	601.45	321.89
Other Income	12.58	20.96	11.58	6.09
Total Income	782.18+16.9%	668.85+9.1%	613.03	327.99
Expenditure	-648.03-6.8%	-606.93-6.8%	-568.38	-348.75
Interest	-0.04	-0.07	-0.09	-25.41
PBDT	0	0	0	0
EBITDA	147.28+131.8%	63.54+6.6%	59.60	32.53
Depreciation	-25.67	-22.51	-26.44	-33.98
EBIT	121.61+196.4%	41.03+23.7%	33.16	-1.45
PBT	134.15+86.8%	71.83+60.9%	44.65	-29.73
Tax	-31.37	-23.58	-16.15	1.15
Equity	13.37	13.37	0	0
OPM (%)	17.15	10.74	7.28	-9.06
Net Profit	102.78+126.8%	45.32+59.0%	28.50	-28.58
NPM (%)	13.14	6.78	4.65	-8.71
EPS (Rs)	76.89+126.8%	33.90+59.1%	21.31	-23.15
CEPS	76.89	33.90	21.31	-23.15

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	10	07 Aug 2026
2013	Final Dividend	3	23 Sep 2013
2012	Final Dividend	3	20 Sep 2012
2011	Final Dividend	3	22 Sep 2011
2010	Final Dividend	3	23 Sep 2010
2009	Final Dividend	3	17 Sep 2009
2008	Final Dividend	4	12 Sep 2008

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split